Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-18-008233
Filing Date
2018-06-05
Accepted
2018-06-05 16:15:13
Documents
2
Period of Report
2018-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm 8-K/A 27816
2 ex17-3.htm EX-17.3 5215
  Complete submission text file 0001493152-18-008233.txt   34322
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36268 | Film No.: 18881278
SIC: 2835 In Vitro & In Vivo Diagnostic Substances